Aridol® in Australia​
​
Aridol (mannitol) is manufactured by Arna Pharma Pty Ltd (Frenchs Forest, Sydney, Australia) and is distributed in Australia by our distributor BTC Pharma Pty Ltd.
The mannitol challenge test (Aridol®) is an indirect osmotic bronchial challenge test that can be used to identify bronchial hyperresponsivesness, a key clinical feature of respiratory conditions such as asthma.
​
Aridol is manufactured by Arna Pharma Pty Ltd (Frenchs Forest, Sydney Australia) and is available as a standardised test kit containing pre-filled mannitol capsules and a hand held dry powder inhaler.
​
During a mannitol challenge test, the subject inhales increasing doses of mannitol with their lung function (forced expiratory volume in one second- FEV1) measured after each dose to determine the level of bronchial hyperresponsiveness.
​
The mannitol challenge test should only be performed by a suitably trained healthcare professional. Please refer to the approved product information or summary of product characteristics for your country prior to performing this challenge test.
​
Please refer to the Approved Aridol Product Information(PI) and Consumer Medicine Information attached below.
​
For more information about Aridol in Australia please contact BTC Pharma Pty Ltd.
Ordering Information is below:
Clifford Hallam Healthcare Pty Ltd (CH2)
Email: hospital@ch2.net.au
Phone: 1300 720 274
[CH2 Code - 2599029 - ARIDOL (mannitol) Kit (1 single kit)}
Product Enquiries
Phone: Toll free number(24x7): 1800 100 282
Email: getintouch@btchealth.com.au
Business hours- Monday to Friday(excluding public holidays) 9:00am - 5:00pm AEST
​
Medical Information and Adverse Events
Email: safety@btchealth.com.au
Phone: 1800 100 282
​
BTC Pharma Pty Ltd
Level 1, 10 Oxley Road
Hawthorn, VIC, 3124 Australia
